Overview


According to FutureWise analysis, the market for Smart Insulin Pens is estimated to be US$ 34.7 million in 2022, and is expected to grow at a CAGR of 11.3% over the forecast of 2023-2031.

A smart insulin pen combines a reusable injector pen with a smartphone app to help individuals with diabetes better regulate their insulin supplies. The majority of diabetic individuals have trouble calculating how much insulin to take. Insulin stacking might be the outcome. By controlling one's diabetes, individuals can improve insulin delivery. These "second-generation" pens connect through USB or Bluetooth, allowing wireless data transmission to the app. With the help of helpful reminders, notifications, and reports, the smart insulin pen calculates and tracks doses. Additional features on the smart insulin pens include data transfer, time and dose recording, and memory function. The growth in prevalence of the two kinds of diabetes, which are brought on by obesity and altered lifestyle and dietary practices, is expected to drive the global market for smart insulin pens.

Modern diabetes care has reached new heights due to smart insulin pens. The information provided by this device enables users to continuously check their blood glucose levels. Users of these devices can receive information that aids in making wise decisions about their dietary intake and medication. Smart insulin pens also allow customers to personalize the device to help them manage their diabetes. The high demand for patient-friendly products drives the demand for technologically advanced goods. Furthermore, during the projected period, increasing consumer awareness of innovative diabetic control technologies is anticipated to drive market expansion.

FutureWise Market Research has published a report that provides an insightful analysis of smart insulin pens market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, the smart insulin pens market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.
  • Novo Nordisk.
  • Sanofi, Eli Lilly and Co.
  • Companion Medical.
  • Emperra GmbH E-Health Technologies.
  • Diabnext.
  • Jiangsu Delfu Medical Device Co. Ltd.
  • Berlin Chemie.
  • Diamesco Co. Ltd.
  • Patients Pending Ltd. 

Recent developments by key players in Smart Insulin Pens Market:

In September 2022- FineGlide, a sterile pen needle designed to work with the most widely used pen devices in India, was introduced by Terumo India for patients who require routine insulin injections or other self-medication.

Due to numerous factors causing obesity and cardiovascular disorders, the prevalence of diabetes is rising. Individuals are now more likely to develop these chronic ailments due to inactivity, which makes a strong healthcare system necessary. Due to the requirement for constant insulin level monitoring in people with diabetes, the market for smart insulin pens is growing daily. For diabetes patients, workflow management can be time-consuming and arduous because it calls for considerable data collection, processing, and assimilation in addition to prompt administration of insulin dosage. Therefore, the benefits of smart insulin pens are anticipated to drive market expansion. Moreover, as the world suffers from the burden of an ever-growing diabetic population, both patients and healthcare stakeholders are looking toward novel therapeutic strategies. Smart insulin pens are, therefore, probably a good fit in this situation. As hospital workflows become more complicated, investments in cloud-based insulin level monitoring technologies are expanding, creating new growth potential. Manufacturers strongly emphasize increasing the accessibility of Bluetooth-connected smart insulin pens because of how simple it is to configure them with a variety of virtual interfaces, including those for Apple and Android operating systems. A considerable increase in type-2 diabetes therapy is also projected, which will enhance market demand. Smart insulin pens for homecare insulin delivery are anticipated to significantly increase in popularity throughout the projected period since the bulk of diabetes in the world is found in the senior population. Using insulin pens at home can help patients manage time while reducing the number of trips to the hospital. Additionally, because they are portable, smart insulin pens are the greatest choice for administering home-grade insulin. However, smart insulin pens and other diabetes treatment options are not widely used because of their high price, particularly in low- and middle-income countries. These regions could lack the funding to support sizable research and development initiatives, leading to a subpar healthcare infrastructure. The high price of insulin pens and the poor reimbursement rates will limit the market's expansion.

By Product

  • Smart Insulin Pen
  • Adaptors for Conventional Pen

By Connectivity

  • Bluetooth
  • USB

By Diabetes Type

  • Type 1 Diabetes
  • Type 2 Diabetes

By Distribution Channel

  • Hospital Pharmacy
  • Online Sales
  • Retail Pharmacy
  • Diabetes Clinics/Centres

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022 due to the presence of key market players and numerous product launches. The increase in diabetes and the expensive cost of smart insulin pumps are additional factors that are anticipated to support regional market expansion. Additionally, rising healthcare spending and supportive government campaigns to raise awareness of advanced diabetes treatment solutions are the main drivers of regional market expansion.
  • Tier 1 players- established companies in the market with major market share
  • Tier 2 players
  • New Entrants
  • Emerging players which are growing rapidly
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data points affecting market growth
  • To provide with an exhaustive analysis on the Smart Insulin Pens Market by product, by connectivity, by diabetes type, by distribution channel and by region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches.
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to:sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data From Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Smart Insulin Pens Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards And Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Smart Insulin Pens Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Smart Insulin Pens Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Smart Insulin Pen
        2. Adaptors for Conventional Pen

  • 8.   Global Smart Insulin Pens Market, By Connectivity Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Bluetooth
        2. USB

  • 9.   Global Smart Insulin Pens Market, By Diabetes Type Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Type 1 Diabetes
        2. Type 2 Diabetes

  • 10.   Global Smart Insulin Pens Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Hospital Pharmacy
        2. Online Sales
        3. Retail Pharmacy
        4. Diabetes Clinics/Centres

  • 11.   North America Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million) along with expected regulatory needs

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Europe Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Switzerland
         2.9. Rest of Western Europe

  • 13.   Asia Pacific Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million) - along with expected regulatory needs

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. Singapore
         2.4. India
         2.5. Australia and New Zealand
         2.6. ASEAN
         2.7. South Korea
         2.8. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Latin America Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Regional Market Trends
        3. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         3.1. Brazil
         3.2. Venezuela
         3.3. Argentina
         3.4. Rest of Latin America
        4. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)

    •   1. Novo Nordisk
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Sanofi
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Eli Lilly and Co.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Companion Medical
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Emperra GmbH E-Health Technologies
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Diabnext
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Jiangsu Delfu Medical Device Co. Ltd.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Berlin Chemie
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Diamesco Co. Ltd.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Patients Pending Ltd.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 17.   FutureWise SME key takeaway points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11